Optimal therapeutic strategy using antigen‐containing liposomes selectively delivered to antigen‐presenting cells
Open Access
- 10 January 2019
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 110 (3) , 875-887
Abstract
Recent immunotherapies have demonstrated clinical success. In particular, vaccines based on particulate antigen (Ag) are expected to be implemented based on their efficacy. In the current study, we describe a strategy entailing Ag‐encapsulating poly(ethylene glycol)‐modified liposomes (PGL‐Ag) as antigen protein delivery devices and show that the success of the liposome depends on the antigen‐presenting cell (APC) capacity; after administration of PGL‐Ag, dendritic cells (DCs) in particular take up the Ag and subsequently prime T cells. For the generation of antitumor T cell responses in the lymphoid tissues, the function of encapsulated Ag‐capturing DCs in vivo could be a biomarker. We next designed a prime‐boost strategy to enhance the antitumor effects of the PGL‐Ag. In the tumor sites, we show that Ag retention in nanoparticle‐capturing DCs promotes a robust antitumor response. Thus, this efficient particulate Ag‐based host APC‐delivery strategy provides a bridge between innate and adaptive immune response and offers a novel therapeutic option against tumor cells.Keywords
This publication has 29 references indexed in Scilit:
- The big picture on nanomedicine: the state of investigational and approved nanomedicine productsNanomedicine: Nanotechnology, Biology and Medicine, 2013
- Challenges in Development of Targeted Liposomal TherapeuticsThe AAPS Journal, 2012
- Intrinsic therapeutic applications of noble metal nanoparticles: past, present and futureChemical Society Reviews, 2012
- Relationship between the size of nanoparticles and their adjuvant activity: Data from a study with an improved experimental designEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- DC therapy induces long‐term NK reactivity to tumors via host DCEuropean Journal of Immunology, 2009
- Nanotechnology in vaccine deliveryAdvanced Drug Delivery Reviews, 2008
- Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune responseBiomaterials, 2007
- Differential Lysosomal Proteolysis in Antigen-Presenting Cells Determines Antigen FateScience, 2005
- PEG-PLA Nanoparticles as Carriers for Nasal Vaccine DeliveryJournal of Aerosol Medicine, 2004
- Analysis of Protease Activity in Live Antigen-presenting Cells Shows Regulation of the Phagosomal Proteolytic Contents During Dendritic Cell ActivationJournal of Experimental Medicine, 2002